Cargando…
Self-Emulsifying Drug Delivery Systems: Hydrophobic Drug Polymer Complexes Provide a Sustained Release in Vitro
[Image: see text] The aim of this study was to develop hydrophobic ionic drug polymer complexes in order to provide sustained drug release from self-emulsifying drug delivery systems (SEDDS). Captopril (CTL) was used as an anionic model drug to form ionic complexes with the cationic polymers Eudragi...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539300/ https://www.ncbi.nlm.nih.gov/pubmed/32841038 http://dx.doi.org/10.1021/acs.molpharmaceut.0c00389 |
_version_ | 1783591030692511744 |
---|---|
author | Malkawi, Ahmad Jalil, Aamir Nazir, Imran Matuszczak, Barbara Kennedy, Ross Bernkop-Schnürch, Andreas |
author_facet | Malkawi, Ahmad Jalil, Aamir Nazir, Imran Matuszczak, Barbara Kennedy, Ross Bernkop-Schnürch, Andreas |
author_sort | Malkawi, Ahmad |
collection | PubMed |
description | [Image: see text] The aim of this study was to develop hydrophobic ionic drug polymer complexes in order to provide sustained drug release from self-emulsifying drug delivery systems (SEDDS). Captopril (CTL) was used as an anionic model drug to form ionic complexes with the cationic polymers Eudragit RS, RL, and E. Complexes of polymer to CTL charge ratio 1:1, 2:1, and 4:1 were incorporated in two SEDDS, namely FA which was 40% Kolliphor RH 40, 20% Kolliphor EL, and 40% castor oil and FB, which was 40% Kolliphor RH 40, 30% glycerol, 15% Kolliphor EL, and 15% castor oil. Blank and complex loaded SEDDS were characterized regarding their droplet size, polydispersity index (PDI), and zeta potential. Resazurin assay was performed on Caco-2 cells to evaluate the biocompatibility of SEDDS. Release of CTL from SEDDS was determined in release medium containing 0.2 mg/mL of 5,5′-dithiobis(2-nitrobenzoic acid) (DNTB) allowing quantification of free drug released into solution via a thiol/disulfide exchange reaction between CTL and DNTB forming a yellow dye. The droplet size of SEDDS FA and SEDDS FB were in the range of 100 ± 20 nm and 40 ± 10 nm, respectively, with a PDI < 0.5. The zeta potential of SEDDS FA and SEDDS FB increased after the incorporation of complexes. Cell viability remained above 80% after incubation with SEDDS FA and SEDDS FB in a concentration of 1% and 3% for 4 h. Without any polymer, CTL was entirely released from both SEDDS within seconds. In contrast, the higher the cationic lipophilic polymer to CTL ratio in SEDDS, the more sustained was the release of CTL. Among the polymers which were evaluated, Eudragit RL provided the most sustained release. SEDDS FA containing Eudragit RL and CTL in a ratio of 1:1 released 64.78 ± 8.28% of CTL, whereas SEDDS FB containing the same complex showed a release of 91.85 ± 1.17% within 1 h. Due to the formation of lipophilic ionic polymer complexes a sustained drug release from oily droplets formed by SEDDS can be achieved. Taking into account that drugs are otherwise instantly released from SEDDS, results of this study might open the door for numerous additional applications of SEDDS for which a sustained drug release is essential. |
format | Online Article Text |
id | pubmed-7539300 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-75393002020-10-07 Self-Emulsifying Drug Delivery Systems: Hydrophobic Drug Polymer Complexes Provide a Sustained Release in Vitro Malkawi, Ahmad Jalil, Aamir Nazir, Imran Matuszczak, Barbara Kennedy, Ross Bernkop-Schnürch, Andreas Mol Pharm [Image: see text] The aim of this study was to develop hydrophobic ionic drug polymer complexes in order to provide sustained drug release from self-emulsifying drug delivery systems (SEDDS). Captopril (CTL) was used as an anionic model drug to form ionic complexes with the cationic polymers Eudragit RS, RL, and E. Complexes of polymer to CTL charge ratio 1:1, 2:1, and 4:1 were incorporated in two SEDDS, namely FA which was 40% Kolliphor RH 40, 20% Kolliphor EL, and 40% castor oil and FB, which was 40% Kolliphor RH 40, 30% glycerol, 15% Kolliphor EL, and 15% castor oil. Blank and complex loaded SEDDS were characterized regarding their droplet size, polydispersity index (PDI), and zeta potential. Resazurin assay was performed on Caco-2 cells to evaluate the biocompatibility of SEDDS. Release of CTL from SEDDS was determined in release medium containing 0.2 mg/mL of 5,5′-dithiobis(2-nitrobenzoic acid) (DNTB) allowing quantification of free drug released into solution via a thiol/disulfide exchange reaction between CTL and DNTB forming a yellow dye. The droplet size of SEDDS FA and SEDDS FB were in the range of 100 ± 20 nm and 40 ± 10 nm, respectively, with a PDI < 0.5. The zeta potential of SEDDS FA and SEDDS FB increased after the incorporation of complexes. Cell viability remained above 80% after incubation with SEDDS FA and SEDDS FB in a concentration of 1% and 3% for 4 h. Without any polymer, CTL was entirely released from both SEDDS within seconds. In contrast, the higher the cationic lipophilic polymer to CTL ratio in SEDDS, the more sustained was the release of CTL. Among the polymers which were evaluated, Eudragit RL provided the most sustained release. SEDDS FA containing Eudragit RL and CTL in a ratio of 1:1 released 64.78 ± 8.28% of CTL, whereas SEDDS FB containing the same complex showed a release of 91.85 ± 1.17% within 1 h. Due to the formation of lipophilic ionic polymer complexes a sustained drug release from oily droplets formed by SEDDS can be achieved. Taking into account that drugs are otherwise instantly released from SEDDS, results of this study might open the door for numerous additional applications of SEDDS for which a sustained drug release is essential. American Chemical Society 2020-08-25 2020-10-05 /pmc/articles/PMC7539300/ /pubmed/32841038 http://dx.doi.org/10.1021/acs.molpharmaceut.0c00389 Text en This is an open access article published under a Creative Commons Attribution (CC-BY) License (http://pubs.acs.org/page/policy/authorchoice_ccby_termsofuse.html) , which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited. |
spellingShingle | Malkawi, Ahmad Jalil, Aamir Nazir, Imran Matuszczak, Barbara Kennedy, Ross Bernkop-Schnürch, Andreas Self-Emulsifying Drug Delivery Systems: Hydrophobic Drug Polymer Complexes Provide a Sustained Release in Vitro |
title | Self-Emulsifying Drug Delivery Systems: Hydrophobic
Drug Polymer Complexes Provide a Sustained Release in Vitro |
title_full | Self-Emulsifying Drug Delivery Systems: Hydrophobic
Drug Polymer Complexes Provide a Sustained Release in Vitro |
title_fullStr | Self-Emulsifying Drug Delivery Systems: Hydrophobic
Drug Polymer Complexes Provide a Sustained Release in Vitro |
title_full_unstemmed | Self-Emulsifying Drug Delivery Systems: Hydrophobic
Drug Polymer Complexes Provide a Sustained Release in Vitro |
title_short | Self-Emulsifying Drug Delivery Systems: Hydrophobic
Drug Polymer Complexes Provide a Sustained Release in Vitro |
title_sort | self-emulsifying drug delivery systems: hydrophobic
drug polymer complexes provide a sustained release in vitro |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539300/ https://www.ncbi.nlm.nih.gov/pubmed/32841038 http://dx.doi.org/10.1021/acs.molpharmaceut.0c00389 |
work_keys_str_mv | AT malkawiahmad selfemulsifyingdrugdeliverysystemshydrophobicdrugpolymercomplexesprovideasustainedreleaseinvitro AT jalilaamir selfemulsifyingdrugdeliverysystemshydrophobicdrugpolymercomplexesprovideasustainedreleaseinvitro AT nazirimran selfemulsifyingdrugdeliverysystemshydrophobicdrugpolymercomplexesprovideasustainedreleaseinvitro AT matuszczakbarbara selfemulsifyingdrugdeliverysystemshydrophobicdrugpolymercomplexesprovideasustainedreleaseinvitro AT kennedyross selfemulsifyingdrugdeliverysystemshydrophobicdrugpolymercomplexesprovideasustainedreleaseinvitro AT bernkopschnurchandreas selfemulsifyingdrugdeliverysystemshydrophobicdrugpolymercomplexesprovideasustainedreleaseinvitro |